E. Okutan et al. / Polyhedron 67 (2014) 344–350
345
themselves around either nanotubes or nanotube bundles. CNT-
2.3. Synthesis
dendrimeric cyclophosphazene systems which disrupt the van
der Waals interactions that cause the insolubility of CNTs show
promise. In this respect, the development of new non-covalent
CNT-dendrimeric cyclophosphazene hybrid materials showing
high thermal stability and solubility in widely used solvents would
be important for the applications of CNT-based systems.
1,1,3,3,5,5,7,7-Octaphenoxy-cyclotetraphosphazatetraene, [NP
(OC6H5)2]4, (1) was prepared according to procedures described
previously [33].
2.3.1. Synthesis of compound (2)
In this research, procedures of non-covalently introducing a
phenoxy-substituted dendrimeric cyclotetraphosphazene (5) onto
the side walls of MWCNTs by non-covalent adsorption and the
spectroscopic, thermal and morphological properties of the soluble
MWCNT-5 nanocomposite, using 31P NMR, XRD, EDX, TGA and
HRTEM techniques, are reported. The fluorescence, Raman and 1H
NMR spectra confirmed the non-covalent functionalization of
MWCNTs with phenoxy groups on the dendrimeric compound.
The hybrid material shows both high thermal stability and
excellent fluorescence quenching efficiency. Also the hybrid
(MWCNT-5) showed significant dispersion stability in common or-
ganic solvents, such as dichloromethane, chloroform, N,N-dimeth-
ylformamide, dimethyl sulfoxide and tetrahydrofuran.
A solution of sodium phenoxide was prepared by the dropwise
addition of phenol (2.1 g, 23 mmol) to a sodium hydride (1.1 g,
28 mmol, 60%) dispersion in dry THF (60 mL) at 0 °C. Octachlorocy-
clotetraphosphazene (1.6 g, 3.3 mmol) in dry THF (30 mL) was
added dropwise to the reaction mixture of sodium phenoxide,
and the resulting mixture was stirred for 0.5 h. The reaction mix-
ture was then stirred for 1 day under an atmosphere of argon
and the reaction was followed by TLC. Sodium chloride was re-
moved by filtration, the solvent was removed under reduced pres-
sure and the resulting product was subjected to column
chromatography using benzene:petroleum ether (1:1) as the elu-
ent. Yield: 2.5 g (80%). Anal. Calc. for [C42H35ClN4O7P4] Found: C,
58.26; H, 4.10; N, 6.40%; requires: C, 58.18; H, 4.07; N, 6.46%. MS
(ESI) m/z (%) Calc.: 866; found: 867 (100) [M+H]+. 31P{1H} NMR
(toluene-d8), assigned as an AB2C spin system d: À4.064 [1P,
P(OPh)Cl, A], À11.65 [2P, P(OPh)2, B2], À11.05 [1P, P(Ph)2, C],
2. Experimental
2
2
2JAB = 55 Hz, JAC = 18 Hz, JCB = 79 Hz. 1H NMR (CDCl3) d: 7.01–
7.29 (m, 35H, ArCH). {1H}13C NMR (CDCl3) d: 151.40 (ArC),
144.30 (ArC), 129.53 (ArCH), 125.44 (ArCH), 124.90 (ArCH),
121.77 (ArCH), 121.28 (ArCH).
2.1. Materials
Octachlorocyclotetraphosphazene (Otsuka Chemical Co. Ltd.)
was purified by fractional crystallization from n-hexane. The deu-
terated solvents (CDCl3 and toluene-d8) for NMR spectroscopy and
the following chemicals were obtained from Merck; cyclohexene,
ethanol, phenol, Pd(OH)2, Cs2CO3, NaH, acetone, triethylamine, sil-
ica gel 60, tetrahydrofuran Ni(NO3)2Á6H2O, MgO and HCl (37%).
1,8,9-Anthracenetriol for the MALDI matrix was obtained from Flu-
ka. Acetylene (99.8%), helium (99.98%) and hydrogen (99.998%)
gases were purchased from Yalız Industrial Medical Gases Inc.
2.3.2. Synthesis of compound (3)
4-(Benzyloxy) phenol (0.54 g, 2.7 mmol), dry and finely pow-
dered cesium carbonate (0.91 g, 2.8 mmol) were dissolved in dry
THF (10 mL) under an argon atmosphere. The solution was trans-
ferred into a dropping funnel (50 mL) and slowly dropped into a
solution of 1,1,3,3,5,5,7-heptaphenoxy-7-chlorocyclotetraphosph-
azatetraene (2 g, 2.3 mmol) (2) in dry THF (10 mL) under an argon
atmosphere in a three necked round bottomed flask (50 mL). The
reaction mixture was refluxed under argon for 24 h and followed
by TLC, until it indicated that no starting material remained. The
precipitated salt (CsCl) was filtered off and the solvent was re-
moved under reduced pressure. The crude product was purified
by column chromatography using silica gel 60 (70–230 mesh) as
the adsorbent and dichloromethane:n-hexane (1:2) as the eluent.
1,1,3,3,5,5,7-Heptaphenoxy-7-[(4-benzyloxy)phenoxy]-cyclo-
tetraphosphazatetraene (3) was obtained as a viscous oil; Yield:
1.65 g (68%). Anal. Calc for [C55H46N4O9P4] Found: C, 64.16; H,
4.55; N, 5.36%; requires: C, 64.08; H, 4.50; N, 5.43%. MS (ESI) m/z
(%) Calc.: 1030; found: 1163 (100) [M+Cs]+. 31P{1H} NMR (tolu-
ene-d8) d: À12.45 (br, s, 4P). 1H NMR (CDCl3) d: 6.61–7.33 (m,
44H, ArCH), 4.89 (br s, 2H, CH2). {1H}13C NMR (CDCl3) d: 155.69
(ArC), 151.60 (ArCH), 145.37 (ArC), 137.28 (ArC), 129.39 (ArCH),
128.87 (ArCH), 127.68 (ArCH), 124.56 (ArCH), 121.26 (ArCH),
115.38 (ArCH), 70.64 (CH2).
2.2. Equipment
Elemental analyses were carried out using a Thermo Finnigan
Flash 1112 Instrument. UV–Vis spectra were recorded with a
Shimadzu 2101 UV spectrophotometer. Fluorescence excitation
and emission spectra were recorded on a Varian Eclipse spectroflu-
orometer using 1 cm pathlength cuvettes at room temperature.
Mass spectra were acquired in linear modes with an average of
50 shots on a Bruker Daltonics Microflex mass spectrometer
(Bremen, Germany) equipped with a nitrogen UV-Laser operating
at 337 nm. Analytical thin layer chromatography (TLC) was
performed on silica gel plates (Merck, Kieselgel 60, 0.25 mm thick-
ness) with F254 indicator. Column chromatography was performed
on silica gel (Merck, Kieselgel 60, 230–400 mesh; for 3 g. crude
mixture, 100 g. silica gel was used in a column 3 cm in diameter
and 60 cm in length) and preparative thin layer chromatography
was performed on silica gel 60 P F254.
1H, 13C and 31P NMR spectra
were recorded in CDCl3 and toluene-d8 solutions on a Varian
500 MHz spectrometer. The thermal properties of the compounds
were investigated on a Mettler Toledo TGA/SDTA 851 Thermo-
gravimetric Analysis (TGA) instrument. The X-ray diffraction
(XRD) patterns of the samples were taken at room temperature
with 2h = 5–40° on a BRUKER D8 Advance X-ray diffractometer
2.3.3. Synthesis of compound (4)
1,1,3,3,5,5,7-Heptaphenoxy-7-[(4-benzyloxy)phenoxy]-cyclo-
tetraphosphazatetraene (3) (1.05 g, 1 mmol) was dissolved in dry
THF (10 mL) under an argon atmosphere and cyclohexene
(10 mL), palladium (II) hydroxide (0.4 g, 20 wt% on carbon) and
ethanol (10 mL) were added to this solution. The mixture was re-
fluxed for 24 h under an argon atmosphere and filtered. All of the
solvents were removed under reduced pressure. 1,1,3,3,5,5,7-Hep-
taphenoxy-7-[(4-hydroxy)phenoxy]cyclotetraphosphazatetraene
(4) was obtained by crystallization from dichloromethane/n-hex-
ane (1:1); Yield: 0.75 g (78%). Anal. Calc for [C48H40N4O9P4] Found:
C, 61.33; H, 4.35; N, 5.89%; requires: C, 61.28; H, 4.29; N, 5.96%. MS
(ESI) m/z (%) Calc.: 940; found: 963 (100) [M+Na]+. 31P{1H} NMR
equipped with a sealed tube copper target (k Cu Ka = 1.54056 Å).
The structural analysis was performed on an automated Renishaw
InVia Reflex Raman microscopy system (Renishaw Plc., New Mills,
Wotton-under-Edge, UK) equipped with a 514 nm laser, which was
used for all of the experiments. The morphology of the composite
(MWCNT-5) was characterized using a Philips-FEI G2 F20 S-Twin
HRTEM. The NMR simulation program, available free of charge,
used was gNMR [32].